Direkt zum Inhalt
  1. Publizieren |
  2. Suche |
  3. Browsen |
  4. Neuzugänge rss |
  5. Open Access |
  6. Rechtsfragen |
  7. EnglishCookie löschen - von nun an wird die Spracheinstellung Ihres Browsers verwendet.

FMR1 expression in human granulosa cells increases with exon 1 CGG repeat length depending on ovarian reserve

Rehnitz, Julia ; Alcoba, Diego D. ; Brum, Ilma S. ; Dietrich, Jens E. ; Youness, Berthe ; Hinderhofer, Katrin ; Messmer, Birgitta ; Freis, Alexander ; Strowitzki, Thomas ; Germeyer, Ariane

In: Reproductive Biology and Endocrinology, 16 (2018), Nr. 65. S. 1-9. ISSN 1477-7827

[thumbnail of 12958_2018_Article_383.pdf]
Vorschau
PDF, Englisch
Download (660kB) | Lizenz: Creative Commons LizenzvertragFMR1 expression in human granulosa cells increases with exon 1 CGG repeat length depending on ovarian reserve von Rehnitz, Julia ; Alcoba, Diego D. ; Brum, Ilma S. ; Dietrich, Jens E. ; Youness, Berthe ; Hinderhofer, Katrin ; Messmer, Birgitta ; Freis, Alexander ; Strowitzki, Thomas ; Germeyer, Ariane steht unter einer Creative Commons Namensnennung 3.0 Deutschland

Zitieren von Dokumenten: Bitte verwenden Sie für Zitate nicht die URL in der Adresszeile Ihres Webbrowsers, sondern entweder die angegebene DOI, URN oder die persistente URL, deren langfristige Verfügbarkeit wir garantieren. [mehr ...]

Abstract

Background: Fragile-X-Mental-Retardation-1- (FMR1)-gene is supposed to be a key gene for ovarian reserve and folliculogenesis. It contains in its 5’-UTR a triplet-base-repeat (CGG), that varies between 26 and 34 in general population. CGG-repeat-lengths with 55–200 repeats (pre-mutation = PM) show instable heredity with a tendency to increase and are associated with premature-ovarian-insufficiency or failure (POI/POF) in about 20%. FMR1-mRNA-expression in leucocytes and granulosa cells (GCs) increases with CGG-repeat-length in PM-carriers, but variable FMR1-expression profiles were also described in women with POI without PM-FMR1 repeat-length. Additionally, associations between low numbers of retrieved oocytes and elevated FMR1-expression levels have been shown in GCs of females with mid-range PM-CGG-repeats without POI. Effects of FMR1-repeat-lengths-deviations (n < 26 or n > 34) below the PM range (n < 55) on ovarian reserve and response to ovarian stimulation remain controversial.

Methods: We enrolled 229 women undergoing controlled ovarian hyperstimulation for IVF/ICSI-treatment and devided them in three ovarian-response-subgroups: Poor responder (POR) after Bologna Criteria, polycystic ovary syndrome (PCO) after Rotterdam Criteria, or normal responder (NOR, control group). Subjects were subdivided into six genotypes according to their be-allelic CGG-repeat length. FMR1-CGG-repeat-length was determined using ALF-express-DNA-sequencer or ABI 3100/3130 × 1-sequencer. mRNA was extracted from GCs after follicular aspiration and quantitative FMR1-expression was determined using specific TaqMan-Assay and applying the ΔΔCT method. Kruskall-Wallis-Test or ANOVA were used for simple comparison between ovarian reserve (NOR, POR or PCO) and CGG-subgroups or cohort demographic data. All statistical analysis were performed with SPSS and statistical significance was set at p ≤ 0.05.

Results: A statistically significant increase in FMR1-mRNA-expression-levels was detected in GCs of PORs with heterozygous normal/low-CGG-repeat-length compared with other genotypes (p = 0.044).

Conclusion: Female ovarian response may be negatively affected by low CGG-alleles during stimulation. In addition, due to a low-allele-effect, folliculogenesis may be impaired already prior to stimulation leading to diminished ovarian reserve and poor ovarian response. A better understanding of FMR1 expression-regulation in GCs may help to elucidate pathomechanisms of folliculogenesis disorders and to develop risk-adjusted treatments for IVF/ICSI-therapy. Herewith FMR1-genotyping potentially provides a better estimatation of treatment outcome and allows the optimal adaptation of stimulation protocols in future.

Dokumententyp: Artikel
Titel der Zeitschrift: Reproductive Biology and Endocrinology
Band: 16
Nummer: 65
Verlag: BioMed Central
Ort der Veröffentlichung: London
Erstellungsdatum: 10 Jul. 2018 12:27
Erscheinungsjahr: 2018
ISSN: 1477-7827
Seitenbereich: S. 1-9
Institute/Einrichtungen: Medizinische Fakultät Heidelberg und Uniklinikum > Universitäts-Frauenklinik
DDC-Sachgruppe: 610 Medizin
Leitlinien | Häufige Fragen | Kontakt | Impressum |
OA-LogoDINI-Zertifikat 2013Logo der Open-Archives-Initiative